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Increasing the amount of physical activity has been observed to ameliorate the progression of Alzheimer’s
disease (AD), as well as enhance neurogenesis. Choi et al. in this issue of Neuron report that the expression
of Presenilin 1 (PS1) variants, responsible for the early onset of familial AD, are capable of mitigating the
regenerative effects associated with increased activity and environmental enrichment likely through changes
in resident microglia and their secreted factors.Normal aging in humans brings with it
a progressive loss in memory and other
cognitive functions and is often exacer-
bated by diseases such as AD. Creating
hope that this bleak outlook can be chal-
lenged, a growing number of studies sug-
gest that increasing the amount of physi-
cal activity can reduce the risk and slow
the progression of AD (Larson et al.,
2006; Pope et al., 2003). Equally fascinat-
ing have been reports in rodents that dur-
ing normal aging as well as in young
adults, increased activity and environ-
mental enrichment (EE) can lead to an in-
crease in the number, and functional out-
put, of neural stem cell populations in the
brain (van Praag et al., 2005). While the
parallels between the human and rodent
studies are intriguing, more work is nec-
essary to causally link EE and physical
activity with increased neurogenesis and
cognitive function in experimental models
and demonstrate its relevance to humans.
In this issue of Neuron, Choi et al. (2008)
add a number of unexpected findings to
our understanding of EE-induced neuro-
genesis that might have relevance for
aging and possibly AD. They report that
PS1 variants causing early-onset familial
AD alter the neurogenic niche in the adultmouse brain through changes in microglia
that spoil the regenerative benefits asso-
ciated with increased physical activity
and EE.
Stem cells in the adult brain have been
observed in mammals, including humans,
primarily in the subventricular zone (SVZ)
of the lateral ventricles and the subgranu-
lar zone (SGZ) of the hippocampus (Lois
and Alvarez-Buylla, 1993). Adult neural
stem/progenitor cells (NPCs) are a rela-
tively quiescent population that can self-
renew and give rise to more rapidly divid-
ing progenitors that in turn produce
neurons (neurogenesis), as well as astro-
cytes and oligodendrocytes (gliogenesis).
Neurons born in the SGZ can become
granule neurons that integrate into the ex-
isting circuitry of the hippocampus and
have been shown increasingly to influ-
ence learning and memory (Dupret et al.,
2007). Previous studies have also estab-
lished that adult NPCs are localized to
specialized microenvironments—or neu-
rogenic niches—composed of surround-
ing cells including astrocytes, oligoden-
drocytes, microglia, and endothelial
cells, as well as soluble factors, mem-
brane-bound molecule,s and extracellular
matrix molecules. Together, the neuro-Neuron 5genic niche is thought to provide the
permissive cues necessary for NPC main-
tenance, differentiation, and neural inte-
gration into the circuitry of the brain
(Alvarez-Buylla and Lim, 2004).
The promise that increased neurogene-
sis in the adult brain could indeed stimu-
late cognitive performance and that EE
or physical activity may be sufficient to
trigger neurogenesis opened the ques-
tions whether adult neurogenesis is im-
paired in illnesses with cognitive dysfunc-
tion such as AD, but also whether EE
could be exploited to stave off age-re-
lated cognitive decline and neurodegen-
eration. To date, proteins involved in the
early-onset genetic forms of AD, including
mutant amyloid precursor protein (APP)
and PS1, have been reported to inter-
fere with NPC function in a number of
mouse models, both under normal and
enriched conditions (Kuhn et al., 2007).
Of special relevance to the current article,
Feng et al. (2001) have shown that tar-
geted deletion of endogenous PS1 in ex-
citatory forebrain neurons in adult mice
inhibits enrichment-induced neurogene-
sis in the dentate gyrus and also leads
to changes in contextual fear memory
functions. This earlier study suggested a9, August 28, 2008 ª2008 Elsevier Inc. 527
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genesis, but Choi et al. (2008) demon-
strate now that in the context of familial
AD with PS1 mutations microglia have
a word as well.
The authors observed that PS1 muta-
tions inhibited the enrichment-induced
increase in NPC proliferation and differen-
tiation and that this inhibition was associ-
ated with changes in microglial cell
number and function (Figure 1). They ex-
amined the effect of wild-type human
PS1 (PS1hWT) and FAD-linked mutant
PS1 variants ubiquitously expressed un-
der control of the prion protein promoter
on the capacity of NPCs to proliferate
and differentiate, both in vivo and in vitro.
In agreement with other reports, EE re-
sulted in a prominent increase in prolifer-
ating cells in the dentate gyrus in PS1hWT
mice; however, this increase was absent
in FAD-linked PS1 mutants. Under stan-
dard housing and activity conditions,
these mutants had no significant effect
on proliferation in the dentate gyrus
(Figure 1A). Interestingly, if they analyzed
the brains of those mice that showed
a particular passion to run on the treadmill
in their enriched housing conditions
(>40% of the 3 hr daily enrichment time)
PS1hWT mice had more dentate granule
cells than their sedentary littermates (Fig-
ure 1B); again, the number of granule cells
in mice expressing PS1 variants was sig-
nificantly reduced. This reduction was
not due to alterations in APP metabolism
(mutant PS1 increases production of
highly amyloidogenic and presumably
neurotoxic Ab derived from APP), since
PS1 mice lacking APP showed similar
patterns of changes. In addition, isolated
NPCs from PS1hWT or PS1 mutant mice
showed no differences in proliferation
pointing toward non-cell-autonomous ef-
fects on NPCs.
Because high-activity EE also resulted
in a significant increase in the number of
microglia in the hippocampus of PS1hWT
mice but caused no change in microglia
numbers in mice expressing PS1 variants,
the authors hypothesized that microglia
may have a role in modulating NPC func-
tion. Microglia, which are the main im-
mune cells of the brain derived from the
myeloid lineage, seem to have a particu-
larly interesting function in the neurogenic
niche. Under homeostatic conditions,
resident microglia have been found to
support the generation of new neurons,
whereas inflammation can turn them
into strong inhibitors of neurogenesis
(Monje et al., 2003; Ziv and Schwartz,
2008). Thus, more hippocampal neuro-
genesis observed with increased physical
activity and EE has been linked to a pro-
nounced increase in activated, presum-
ably beneficial microglia, and blocking
this activity by immunosuppressive drugs
impaired their neurogenic, regenerative
function (Ziv et al., 2006).
Although they could not establish a di-
rect causal relationship between micro-
glial changes and neurogenesis in vivo,
Choi and colleagues (2008) present a se-
ries of intriguing cell culture experiments
that link PS1 mutations in microglia to
changes in the secretory profile of signal-
ing proteins and in turn to NPC function
(Figure 1). They show that microglia iso-
lated from PS1hWT mice or supernatants
from these cells promote proliferation of
primary mouse NPCs, whereas microglia
expressing PS1 variants retard prolifera-
tion. This effect is observed both when
microglia are in a resting state or when
they are activated by interleukin-4
(IL-4)—a cytokine that has been proposed
to steer microglia toward a neurogenic
function mimicking EE (Ziv et al., 2006).
Similar results were obtained with orga-
notypic hippocampal slice cultures, sug-
gesting that microglia secrete soluble
factors that regulate neurogenesis. The
precise role or possible origin of IL-4 in
neurogenesis and in the CNS in general
is poorly defined, but this cytokine may
open an interesting tool to modulating mi-
croglial function. Of note and as pointed
out by the authors, PS1 mutant-derived
microglial factors promoted differentia-
tion of NPCs into GFAP-positive glia in
cell culture, but this was not observed
in vivo (Figure 1C). While this suggests dif-
ferences in the two model systems exist, it
should not distract from the observation
that neurogenesis is reduced in vitro and
Figure 1. Neurogenesis Is Induced by High-Activity EE and Modulated by Changes in
Microglia
High-activity EE is defined as EE conditions in which mice spent >40% of time on a running wheel.
(A) Under standard housing conditions, the ubiquitous expression of PS1hWT or PS1 variants does not
interfere with adult neurogenesis.
(B) EE and running in particular increases in the number of microglia, NPCs, and neurogenesis, and this is
not disrupted by the expression of PShWT.
(C) Expression of PS1 variants mitigates the effects of high activity EE. The number of microglia, NPC pro-
liferation, and neurogenesis within the neurogenic niche of the hippocampus are decreased. Changes in
the secreted factors from microglia (derived from PS1 variant transgenic mice) are sufficient to inhibit wild-
type NPC proliferation and neurogenesis, as well as preferentially lead to glia differentiation in vitro.528 Neuron 59, August 28, 2008 ª2008 Elsevier Inc.
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pression. Still, the more general question
remains whether microglia are indeed di-
rectly responsible for the observed inhibi-
tion of EE-induced neurogenesis by PS1
and which factors mediate this effect.
Toward the latter question, the authors
use an innovative way to survey changes
in 62 different cytokines and secreted sig-
naling molecules in conditioned media
from resting and IL-4-activated PS1hWT
and mutant microglia using antibody-
based filter arrays. A number of interest-
ing leads were found to be increased at
the transcript and protein level in PS1 mu-
tant microglia, including tissue inhibitor
of metalloproteinase-1 (TIMP)-1, the che-
mokines CCL5 and CXCL1, as well as
IL-6, some of which have previously been
implicated in NPC biology. Remarkably,
freshly isolated microglia from EE-housed
mice seem to have different levels of ex-
pression for some of these factors and
show evidence of activation by IL-4.
These findings are exciting and offer
much food for thought and future experi-
ments. They also expose our rudimentary
understanding of microglia biology and
the role of classical immune signaling
molecules in neurogenesis and probably
CNS function in general.
While this study begins to elucidate the
role of microglia, and subsequently their
secreted factors, as potential avenues of
NPC regulation, such in vitro results
must be validated in an in vivo model.
Microglia have been unmasked recently
to contribute to the disease process in
superoxide dismutase (SOD) 1 mouse
models of amyotophic lateral sclerosisby deleting this gene in microglia and
thus extending survival (Boillee et al.,
2006). Perhaps developing genetic
models in which PS1 variants are ex-
pressed exclusively by microglia may
lead to additional insights into how
changes in resident microglia of the hip-
pocampus directly influence adult NPCs
in vivo. Such models may also prove inte-
gral in elucidating at a cellular level how
presenilin mutations cause these micro-
glial changes. According to the authors,
APP or notch signaling are not involved.
Additionally, applying such genetic
models toward behavioral studies may
help to tease apart how changes to the
neurogenic niche lead to cognitive
impairments.
In the end, the findings by Choi and co-
workers also serve to highlight the impor-
tance of the neurogenic niche, in which
non-cell-autonomous signaling changes
may help to explain the diminishing regen-
erative potential attributed to other vari-
ables such as aging and possibly neuro-
degeneration itself. It is therefore most
interesting to ask how other components
of the neurogenic niche may contribute
to the (mis)regulation and decline of NPC
function with age and disease and
whether some of these cues may even
come from the periphery. Indeed,
changes in the activity of microglia in-
duced by EE may reflect more global
changes in the organism itself. Identifying
how changes to the molecular composi-
tion of the neurogenic niche regulate the
activity of NPC populations may provide
opportunities toward the development of
regenerative therapeutics to directly com-Neuronbat both degenerative disease and nor-
mal age-related impairments.
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